Cargando…
The Role of Contactin 1 in Cancers: What We Know So Far
Cancers are among the difficult-to-treat diseases despite advances in diagnosis and treatment. Although newer effective targets remain to be discovered, targeted therapy has emerged as a promising field. In the last decade, contactin 1 (CNTN1) has surfaced as an important cancer-related molecule. CN...
Autores principales: | Liang, Yumei, Ma, Cui, Li, Fengjuan, Nie, Guanhua, Zhang, Haining |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658624/ https://www.ncbi.nlm.nih.gov/pubmed/33194679 http://dx.doi.org/10.3389/fonc.2020.574208 |
Ejemplares similares
-
What we know so far
Publicado: (2021) -
Bacteria-Mediated Oncogenesis and the Underlying Molecular Intricacies: What We Know So Far
por: Prasad, Shashanka K., et al.
Publicado: (2022) -
Anabaenopeptins: What We Know So Far
por: Monteiro, Patrick Romano, et al.
Publicado: (2021) -
Undifferentiated Pancreatic Carcinoma With Osteoclast-Like Giant Cells: What Do We Know So Far?
por: Demetter, Pieter, et al.
Publicado: (2021) -
COVID-19 and cancer: what we know so far
por: Sidaway, Peter
Publicado: (2020)